IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IRLAB Therapeutics AB
Accumulated Depreciation Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Accumulated Depreciation
-kr16.4m
CAGR 3-Years
-46%
CAGR 5-Years
-63%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Accumulated Depreciation
-kr2.2m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Accumulated Depreciation?
Accumulated Depreciation
-16.4m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Accumulated Depreciation amounts to -16.4m SEK.

What is IRLAB Therapeutics AB's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 5Y
-63%

Over the last year, the Accumulated Depreciation growth was -36%. The average annual Accumulated Depreciation growth rates for IRLAB Therapeutics AB have been -46% over the past three years , -63% over the past five years .

Back to Top